Regulation of human peptide transporter 1 (PEPT1) in gastric cancer cells by anticancer drugs

Cancer Letters

Volumn 230, Issue 1, 2005, Pages 72-80

  Inoue, Mayumi ^a   Terada, Tomohiro ^a   Okuda, Masahiro ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

5 Fluorouracil; Cisplatin; Gastric cancer; Peptide transporter

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; GLUCOSE TRANSPORTER 1; MESSENGER RNA; PEPTIDE TRANSPORTER 1;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; STOMACH CANCER;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CISPLATIN; FLUOROURACIL; GLUCOSE TRANSPORTER TYPE 1; HUMANS; RNA, MESSENGER; STOMACH NEOPLASMS; SYMPORTERS; TUMOR CELLS, CULTURED;

EID: 27144535106     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.12.023     Document Type: Article

References (27)

1. T. Terada, and K. Inui Peptide transporters: structure, function, regulation and application for drug delivery Curr. Drug Metab. 5 2004 85 94
2. D.E. Gonzalez, K.M. Covitz, W. Sadee, and R.J. Mrsny An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2 Cancer Res. 58 1998 519 525
3. +-peptide cotransport in the human bile duct epithelium cell line SK-ChA-1 Am. J. Physiol. Gastrointest. Liver Physiol. 283 2002 G222 G229
4. T. Nakanishi, I. Tamai, A. Takaki, and A. Tsuji Cancer cell-targeted drug delivery utilizing oligopeptide transport activity Int. J. Cancer 88 2000 274 280
5. J. Neumann, and M. Brandsch δ-aminolevulinic acid transport in cancer cells of the human extrahepatic biliary duct J. Pharmacol. Exp. Ther. 305 2003 219 224
6. S.A. Adibi Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease Am. J. Physiol. Gastrointest. Liver Physiol. 285 2003 G779 G788
7. H. Tanaka, K.I. Miyamoto, K. Morita, H. Haga, H. Segawa, and T. Shiraga Regulation of the PepT1 peptide transporter in the rat small intestine in response to 5-fluorouracil-induced injury Gastroenterology 114 1998 714 723
8. J. Satoh, T. Tsujikawa, Y. Fujiyama, and T. Bamba Nutritional benefits of enteral alanyl-glutamine supplementation on rat small intestinal damage induced by cyclophosphamide J. Gastroenterol. Hepatol. 18 2003 719 725
9. 2-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line J. Pharmacol. Exp. Ther. 294 2000 466 472
10. +/peptide transporter PEPT1 in the human intestinal cell line Caco-2 Biochem. Biophys. Res. Commun. 261 1999 242 246
11. K.F. Becker, G. Keller, and H. Hoefler The use of molecular biology in diagnosis and prognosis of gastric cancer Surg. Oncol. 9 2000 5 11
12. W. Yasui, N. Oue, R. Ito, K. Kuraoka, and H. Nakayama Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications Cancer Sci. 95 2004 385 392
13. +/peptide cotransporter mediating absorption of β-lactam antibiotics in the intestine and kidney J. Pharmacol. Exp. Ther. 275 1995 1631 1637
14. +/peptide cotransporter, PEPT1 FEBS Lett. 394 1996 196 200
15. K. Ashida, T. Katsura, H. Motohashi, H. Saito, and K. Inui Thyroid hormone regulates the activity and expression of the peptide transporter PEPT1 in Caco-2 cells Am. J. Physiol. Gastrointest. Liver Physiol. 282 2002 G617 G623
16. T. Terada, K. Sawada, H. Saito, Y. Hashimoto, and K. Inui Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2 Am. J. Physiol. 276 1999 G1435 G1441
17. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
18. T. Kurokawa, Y. Yoshida, K. Kawahara, T. Tsuchida, H. Okazawa, and Y. Fujibayashi Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary Int. J. Cancer 109 2004 926 932
19. M. Kunkel, T.E. Reichert, P. Benz, H.A. Lehr, J.H. Jeong, and S. Wieand Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma Cancer 97 2003 1015 1024
20. Y. Noguchi, A. Saito, Y. Miyagi, S. Yamanaka, D. Marat, and C. Doi Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth Cancer Lett. 154 2002 175 182
21. 0/ASCT2 elicits apoptosis in human hepatoma cells Am. J. Physiol. Gastrointest. Liver Physiol. 286 2004 G467 G478
22. D.B. Longley, D.P. Harkin, and P.G. Johnston 5-fluorouracil: mechanisms of action and clinical strategies Nat. Rev. Cancer 3 2003 330 338
23. M. Osaki, S. Tatebe, A. Goto, H. Hayashi, M. Oshimura, and H. Ito 5-Fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene Apoptosis 2 1997 221 226
24. I.D. Jung, S.Y. Yang, C.G. Park, K.B. Lee, J.S. Kim, and S.Y. Lee 5-Fluorouracil inhibits nitric oxide production through the inactivation of IκB kinase in stomach cancer cells Biochem. Pharmacol. 64 2002 1439 1445
25. X. Pan, T. Terada, M. Okuda, and K. Inui Altered diurnal rhythm of intestinal peptide transporter by fasting and its effects on the pharmacokinetics of ceftibuten J. Pharmacol. Exp. Ther. 307 2003 626 632
26. H. Ogihara, T. Suzuki, Y. Nagamachi, K. Inui, and K. Takata Peptide transporter in the rat small intestine: ultrastructural localization and the effect of starvation and administration of amino acids Histochem. J. 31 1999 169 174
27. K. Izuishi, K. Kato, T. Ogura, T. Kinoshita, and H. Esumi Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy Cancer Res. 60 2000 6201 6207